Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
172.4 USD | -2.09% | +4.80% | -3.89% |
May. 02 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
May. 01 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.89% | 9.84B | |
-4.84% | 182B | |
+3.71% | 112B | |
-2.80% | 68.58B | |
+5.22% | 51.58B | |
+7.58% | 44.24B | |
+9.45% | 43.65B | |
+25.51% | 32.46B | |
+20.94% | 25.99B | |
+1.06% | 25.61B |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- Transcript : Repligen Corporation, Q4 2022 Earnings Call, Feb 22, 2023